Clinical Trial Update: Senolytics for Secondary Progressive MS [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating senolytic therapies for secondary progressive multiple sclerosis, sponsored by Ohio State University; the study status is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis

Drugs mentioned

• Senolytics

Snippet

Sponsor: Ohio State University | Conditions: Multiple Sclerosis (MS) Secondary Progressive | Phase 1 | Status: NOT_YET_RECRUITING